ZGN trades 9.3% below Wall Street's consensus target of $13.68.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ZGN achieves its forward estimates and maintains a stable P/E multiple of 31.5x. This scenario reflects the blended consensus of 6 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of October 3, 2026, Ermenegildo Zegna N.V. (ZGN) has a Wall Street consensus price target of $13.68, based on estimates from 6 covering analysts. With the stock currently trading at $12.52, this represents a potential upside of +9.3%. The company has a market capitalization of $3.36B.
Analyst price targets range from a low of $12.20 to a high of $15.50, representing a 24% spread in expectations. The median target of $13.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ZGN trades at a trailing P/E of 30.1x and forward P/E of 31.5x. Analysts expect EPS to grow -38.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $31.75, with bear and bull scenarios of $20.01 and $41.84 respectively. Model confidence stands at 37/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 CPRICapri Holdings Limited | $1.7B | $14.44 | $20.57 | +42.5% | Hold | 10.3x | 54 |
 TPRTapestry, Inc. | $23.9B | $118.12 | $174.64 | +47.8% | Buy | 16.9x | 41 |
 RLRalph Lauren Corporation | $22.2B | $363.60 | $456.67 | +25.6% | Buy | 22.3x | 48 |
 PVHPVH Corp. | $3.5B | $75.53 | $91.00 | +20.5% | Buy | 6.9x | 38 |
 HBIHanesbrands Inc. | $2.3B | $6.47 | $7.25 | +12.1% | Buy | 9.8x | 34 |
 GIIIG-III Apparel Group, Ltd. | $1.2B | $27.37 | $34.75 | +27.0% | Buy | 9.4x | 29 |
 OXMOxford Industries, Inc. | $372M | $24.93 | $39.00 | +56.4% | Buy | 11.2x | 21 |
 VFCV.F. Corporation | $5.6B | $14.33 | $18.33 | +27.9% | Hold | 17.4x | 58 |
 MOVMovado Group, Inc. | $772M | $33.66 | $50.00 | +48.5% | Hold | 29.7x | 13 |
 NKENIKE, Inc. | $50.1B | $33.87 | $38.39 | +13.3% | Buy | 20.8x | 72 |
Quick answers to the most common questions about buying ZGN stock.
The consensus price target for ZGN is $13.68, close to the current price of $12.52 (9.3% implied move). Based on 6 analyst estimates, the stock appears fairly valued near current levels.
ZGN has a consensus rating of "Buy" based on 6 Wall Street analysts. The rating breakdown is predominantly bullish, with 4 Buy/Strong Buy ratings. The consensus 12-month price target of $13.68 implies 9.3% upside from current levels.
ZGN trades at a forward P/E of 31.4969x, representing a moderate valuation. With analysts targeting $13.68 (9.3% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $15.5 for ZGN, while the most conservative target is $12.2. The consensus of $13.68 represents the median expectation. Our quantitative valuation model projects a bull case target of $42 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ZGN is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ZGN stock forecast based on 6 Wall Street analysts shows a consensus price target of $13.68, with estimates ranging from $12.2 (bear case) to $15.5 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $32, with bear/bull scenarios of $20/$42.
Our quantitative valuation model calculates ZGN's fair value at $32 (base case), with a bear case of $20 and bull case of $42. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 37/100.
ZGN trades at a forward P/E ratio of 31.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 30.1x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
ZGN appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $13.68 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ZGN analyst price targets range from $12.2 to $15.5, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $13.68 consensus represents the middle ground. Our model's $20-$42 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.